Evidence map›Paper›PMID 25113742›Full record

ReviewEuropean journal of pediatrics2014

Streptococcal pharyngitis in children: to treat or not to treat?

Daan Van Brusselen, Erika Vlieghe, Petra Schelstraete, Frederic De Meulder, Christine Vandeputte, Kristien Garmyn, Wim Laffut, Patrick Van de Voorde

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 63 citations in OpenAlex.

  1. Pooled it
  2. Different antibiotic treatments for group A streptococcal pharyngitis.The Cochrane database of systematic reviews · 2023
    Pooled it
  3. Different antibiotic treatments for group A streptococcal pharyngitis.The Cochrane database of systematic reviews · 2021
    Pooled it
  4. Trial
  5. Review
  6. Peaks in online inquiries into pharyngitis-related symptoms correspond with annual incidence rates.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Penicillin for streptococcal pharyngitis: Is it time for a new paradigm in Canada?Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2019
    Article
  12. Immunity-targeted approaches to the management of chronic and recurrent upper respiratory tract disorders in children.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2019
    Review
  13. Recurrent group AScience translational medicine · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Different antibiotic treatments for group A streptococcal pharyngitis.The Cochrane database of systematic reviews · 2016
    Review
  18. Article
  19. Article
  20. Operator Influence on Blinded Diagnostic Accuracy of Point-of-Care Antigen Testing for Group A Streptococcal Pharyngitis.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Daan Van BrusselenDepartment of Pediatrics, University of Leuven, Herestraat 49, 3000, Leuven, Belgium, daan.vanbrusselen@gmail.com.
Erika Vlieghe
Petra Schelstraete
Frederic De Meulder
Christine Vandeputte
Kristien Garmyn
Wim Laffut
Patrick Van de Voorde
Ghent University Hospital · BEGZA Ziekenhuizen Campus Sint-Augustinus · BEHartcentrum Hasselt · BEKU Leuven · BEUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledControversy remains about the need for antibiotic therapy of group A streptococcal (GAS) pharyngitis in high-resource settings. Guidelines on the management of GAS pharyngitis differ considerably, especially in children. We performed a literature search on the diagnosis and treatment of GAS pharyngitis in children and compared different guidelines with current epidemiology and the available evidence on management. Some European guidelines only recommend antibiotic treatment in certain high-risk patients, while many other, including all American, still advise antimicrobial treatment for all children with GAS pharyngitis, given the severity and re-emerging incidence of complications. Empirical antimicrobial treatment in children with sore throat and a high clinical suspicion of GAS pharyngitis will still result in significant overtreatment of nonstreptococcal pharyngitis. This is costly and leads to emerging antibiotic resistance. Early differential diagnosis between viral and GAS pharyngitis, by means of a 'rapid antigen detection test' (RADT) and/or a throat culture, is therefore needed if 'pro treatment' guidelines are used.

conclusionLarge scale randomized controlled trials are necessary to assess the value of antibiotics for GAS pharyngitis in high-resource countries, in order to achieve uniform and evidence-based guidelines. The severity and the possibly increasing incidence of complications in school-aged children suggests that testing and treating proven GAS pharyngitis can still be beneficial.

Indexed as

Anti-Bacterial AgentsChildHumansPharyngitisPractice Guidelines as TopicStreptococcal InfectionsStreptococcus pyogenesAnti-Bacterial Agents

Identifiers

PMID25113742
OpenAlexW2048634712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.